Access cutting-edge lupus nephritis treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access lupus nephritis specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lupus nephritis treatment provided free
This trial will evaluate efficacy, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or every 12 weeks (q12w) compared to placebo, in combination with SoC, in adult participants with active LN
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this lupus nephritis clinical trial in Los Angeles, CA
If you're searching for lupus nephritis treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus nephritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.